➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Medtronic
Dow
Colorcon
AstraZeneca

Last Updated: August 15, 2020

DrugPatentWatch Database Preview

DEMEROL Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Demerol, and what generic alternatives are available?

Demerol is a drug marketed by Hospira and Us Pharm Holdings and is included in two NDAs.

The generic ingredient in DEMEROL is meperidine hydrochloride. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the meperidine hydrochloride profile page.

Drug patent expirations by year for DEMEROL
Drug Prices for DEMEROL

See drug prices for DEMEROL

Recent Clinical Trials for DEMEROL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Centre hospitalier de l'Université de Montréal (CHUM)Phase 3
Monica BhatiaPhase 1
Ufuk UniversityPhase 4

See all DEMEROL clinical trials

Pharmacology for DEMEROL
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

US Patents and Regulatory Information for DEMEROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira DEMEROL meperidine hydrochloride INJECTABLE;INJECTION 021171-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Us Pharm Holdings DEMEROL meperidine hydrochloride INJECTABLE;INJECTION 005010-009 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira DEMEROL meperidine hydrochloride INJECTABLE;INJECTION 021171-004 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Us Pharm Holdings DEMEROL meperidine hydrochloride INJECTABLE;INJECTION 005010-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira DEMEROL meperidine hydrochloride INJECTABLE;INJECTION 021171-002 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Hospira DEMEROL meperidine hydrochloride INJECTABLE;INJECTION 021171-003 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Boehringer Ingelheim
Medtronic
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.